Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;10(1):490-501.
doi: 10.1080/21505594.2019.1614383.

Basic Principles of the Virulence of Cryptococcus

Free PMC article

Basic Principles of the Virulence of Cryptococcus

Oscar Zaragoza. Virulence. .
Free PMC article


Among fungal pathogens, Cryptococcus neoformans has gained great importance among the scientific community of several reasons. This fungus is the causative agent of cryptococcosis, a disease mainly associated to HIV immunosuppression and characterized by the appearance of meningoencephalitis. Cryptococcal meningitis is responsible for hundreds of thousands of deaths every year. Research of the pathogenesis and virulence mechanisms of this pathogen has focused on three main different areas: Adaptation to the host environment (nutrients, pH, and free radicals), mechanism of immune evasion (which include phenotypic variations and the ability to behave as a facultative intracellular pathogen), and production of virulence factors. Cryptococcus neoformans has two phenotypic characteristics, the capsule and synthesis of melanin that have a profound effect in the virulence of the yeast because they both have protective effects and induce host damage as virulence factors. Finally, the mechanisms that result in dissemination and brain invasion are also of key importance to understand cryptococcal disease. In this review, I will provide a brief overview of the main mechanisms that makes C. neoformans a pathogen in susceptible patients. Abbreviations: RNS: reactive nitrogen species; BBB: brain blood barrier; GXM: glucuronoxylomannan; GXMGal: glucuronoxylomannogalactan.

Keywords: Cryptococcus; capsule; melanin; titan cell; virulence.

Similar articles

See all similar articles

Cited by 3 articles


    1. Brown GD, Denning DW, Gow NA, et al. Hidden killers: human fungal infections. Sci Transl Med. 2012;4:165rv13. - PubMed
    1. Drgona L, Khachatryan A, Stephens J, et al. Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species. Eur J Clin Microbiol Infect Dis. 2014;33:7–21. - PMC - PubMed
    1. Menzin J, Meyers JL, Friedman M, et al. The economic costs to United States hospitals of invasive fungal infections in transplant patients. Am J Infect Control. 2011;39:e15–20. - PubMed
    1. Casadevall A, Perfect JR. Cryptococcus neoformans. Washington DC: ASM Press; 1998.
    1. Heitman J, Kozel TR, Kwon-Chung KJ, et al. Cryptococcus. From human pathogen to model yeast. Washington (DC): ASM Press; 2011.

Publication types

Grant support

O.Z. is funded by grants SAF2014-54336-R and SAF2017-86192-R1 from the Spanish Ministry for Economics, Industry and Competitivity. The author has no conflict of interest to declare; Ministerio de Economía, Industria y Competitividad, Gobierno de España [SAF2017-86192-R1];Ministerio de Economía, Industria y Competitividad, Gobierno de España [SAF2014-54336R].

LinkOut - more resources